Lysine inhibitors represent a specific category of chemical compounds that interact with lysine residues in proteins to modulate their activity, stability, or interactions with other molecules. Lysine is one of the 20 standard amino acids and plays a crucial role in protein structure and function due to its positive charge and ability to form multiple hydrogen bonds. Inhibitors targeting lysine residues often function by chemically modifying the lysine's side chain, preventing it from engaging in its typical interactions or altering its structural configuration. These modifications can occur through various chemical reactions, including acetylation, methylation, ubiquitination, and sumoylation, each of which adds a different chemical group to the lysine side chain. The inhibitors can be designed to either mimic the natural substrates and intermediates of these reactions or to bind to the enzymes responsible for adding or removing these modifications, effectively regulating the post-translational modification state of the lysine residues.
The ability to manipulate lysine residues in proteins holds significant promise for understanding and modulating biological processes at the molecular level. Lysine modifications are involved in numerous cellular processes, including protein-protein interactions, localization, stability, and activity. Inhibitors that target these modifications can help dissect the functional roles of specific lysine residues or modifications in a given protein or cellular pathway. For instance, inhibitors of lysine acetyltransferases (KATs) or deacetylases can be used to study how acetylation affects protein function, while inhibitors of ubiquitin ligases can shed light on the role of ubiquitination in protein degradation. Additionally, lysine modifications can also play roles in the regulation of transcription, as certain histone lysine residues are critical for modulating chromatin structure and gene expression. By targeting these modifications, lysine inhibitors provide powerful tools for probing the intricacies of cellular regulation and the molecular mechanisms underlying various biological phenomena.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin is known to exhibit histone deacetylase (HDAC) inhibitory activity, which could potentially increase acetylation levels in proteins, potentially altering the binding efficiency of Ac-lysine Antibodies. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate acts as an HDAC inhibitor, potentially increasing the acetylation of lysine residues in histones and other proteins. This alteration may influence the recognition and binding of Ac-lysine Antibodies. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a potent HDAC inhibitor, which may lead to increased acetylation of lysine residues in proteins, possibly affecting Ac-lysine Antibody binding. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $100.00 $200.00 | 13 | |
Anacardic acid has been reported to inhibit histone acetyltransferase (HAT) activity, potentially reducing lysine acetylation and affecting Ac-lysine Antibody binding. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
C646 is a selective HAT inhibitor, potentially reducing acetylation levels on lysine residues and influencing the binding of Ac-lysine Antibodies. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $136.00 $492.00 | 13 | |
Garcinol exhibits HAT inhibitory activity, which could potentially decrease the acetylation of lysine residues in proteins and affect Ac-lysine Antibody binding. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat is an HDAC inhibitor that could increase acetylation levels on lysine residues, potentially altering Ac-lysine Antibody recognition and binding. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Panobinostat is a broad-spectrum HDAC inhibitor that could enhance lysine acetylation, potentially influencing Ac-lysine Antibody binding. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $43.00 $65.00 $200.00 $815.00 | 6 | |
Nicotinamide is a form of vitamin B3 that has been shown to inhibit HDAC activity, potentially increasing acetylation of lysine residues and affecting Ac-lysine Antibody binding. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid is known to have HDAC inhibitory activity, which could lead to increased lysine acetylation and potentially influence Ac-lysine Antibody binding. | ||||||